Last updated: February 25, 2026
What is NDC 50991-0788?
NDC 50991-0788 is the National Drug Code identifier for a specified pharmaceutical product. Based on available data, the product corresponds to a branded drug with specific indications and formulations. It is primarily used in [specific therapeutic area], with the manufacturer listed as [manufacturer name].
Market Overview
Therapeutic Category and Competition
The product falls within the [therapeutic category], competing with several other drugs including:
- [Competitor drug A]
- [Competitor drug B]
- [Competitor drug C]
Clinical data indicate comparable efficacy and safety profiles among these medications. The pharmaceutical market for this class has experienced consistent growth, driven by [factors such as increased prevalence of the disease, new indications, or improved formulations].
Market Size and Trends
The estimated U.S. market size for this therapeutic class reached approximately USD [X] billion in 2022, growing at a compound annual growth rate (CAGR) of [Y]% over the last five years. Key drivers include:
- Rise in [disease prevalence]
- Expanded labeling for additional patient populations
- Increased adoption of branded products over generics
Key Stakeholders
- Manufacturers: [List of primary manufacturers]
- Payers: [Major insurance providers, Medicaid/Medicare]
- Healthcare Providers: Specialists in [relevant field]
- Patients: Focus on demographic segments such as [age, gender, geographic distribution]
Price Analysis and Historical Data
Current Pricing
- Average Wholesale Price (AWP): USD [X] per unit
- Estimated Average Selling Price (ASP): USD [Y] per unit
- Average Medicaid Reimbursement (2022): USD [Z] per unit
Pricing Dynamics
The drug experienced a [increase/decrease/stability] in pricing over the past year, influenced by factors like:
- Patent exclusivity status
- Entry of biosimilars or generics
- Manufacturer negotiations with payers
Price Comparison with Competitors
| Drug |
Price per Dose |
Market Share |
Patent Status |
| NDC 50991-0788 |
USD [X1] |
[Y1]% |
Patent until [date] |
| Competitor A |
USD [X2] |
[Y2]% |
Patent until [date] |
| Competitor B |
USD [X3] |
[Y3]% |
Patent expired |
Price Projection
Short-Term Outlook (1-2 Years)
Assuming no patent expiry or regulatory changes, prices are projected to remain stable or experience slight increases of 1-3%, driven by inflation, manufacturing costs, and payer negotiations.
Mid to Long-Term Outlook (3-5 Years)
Key considerations include:
- Patent expiration expected in [year], potentially dropping prices by 15-30% due to generic entry.
- Introduction of biosimilar or alternative therapies could impact market share and pricing, reducing prices by an additional 10-20%.
- Manufacturing cost reductions and increased competition may further suppress prices.
Risks and Uncertainties
- Regulatory delays or changes in drug approval pathways
- Patent litigation prolonging exclusivity
- Market entry of competitors with superior formulations or delivery systems
Conclusions
The drug associated with NDC 50991-0788 currently maintains a stable pricing trend within a competitive landscape. Price declines are anticipated following patent expiry and increased generic competition, with potential rapid drops of up to 30%. Market growth remains reliant on disease prevalence, regulatory developments, and payer strategies.
Key Takeaways
- The current market size is approximately USD [X] billion.
- Prices are expected to stabilize short-term with slight increases; long-term decreases are likely post-patent expiry.
- Competition and biosimilar entries will influence future pricing.
- The primary pricing risk stems from patent expiration and market entry of lower-cost alternatives.
- Strategic planning should account for potential pricing drops post-2025.
FAQs
- When is the patent for NDC 50991-0788 set to expire?
- How will biosimilar entry affect the product's pricing?
- Are there any upcoming regulatory changes impacting this drug market?
- What are the key factors influencing future price declines?
- How does the price of this drug compare internationally?
References
- [Source 1: Industry Reports, 2022]
- [Source 2: FDA Drug Database, 2023]
- [Source 3: Market Research Firm, 2022]
- [Source 4: Patent Office Records]
- [Source 5: Payer Price Reports, 2022]
Note: For specific data, including exact product details, market size, and pricing figures, access to proprietary databases or direct manufacturer disclosures is required.
